Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
This week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the ...
Singapore’s Health Sciences Authority (HSA) has expanded regulatory reliance and cooperation activities with partners in ...
CHARLOTTE, NC — A panel of experts representing the European Commission, industry, and notified bodies reviewed the state ...
RAPS Convergence 2026 is an opportunity for regulatory professionals to reflect on the evolution of the profession, look ...
The US Food and Drug Administration (FDA) announced on Tuesday the launch of a pilot program designed to expedite the review ...
Singapore’s Parliament has advanced legislation to build “a more coherent, future-ready system” that provides clarity and ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and ...
Top US Food and Drug Administration (FDA) officials said the agency is open to novel, “innovative approaches” to the clinical ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results